Table 4.

Cytogenetic subgroup comparisons in patients with and without trisomy 8*

With trisomy 8Without trisomy 8P
MedianRangeNMedianRangeN
Peripheral blasts (%)        
 Favorable 11 0-79 22 31% 0%-97% 140 .048 
 Intermediate 10 0-95 47 35% 0%-99% 313 .0088 
 Unfavorable 11 0-99 34 24% 0%-99% 225 .27 
WBC (1000/mm3)        
 Favorable 4.7 0.8-60.6  23 7.3 0.5-206.4 150 .55 
 Intermediate 7.4 1.1-104.6 50 19.7 0.3-274.0 330 .0061 
 Unfavorable 6.2 0.8-271.2 34 8.3 0.6-230.0 234 .64 
Age (y)        
 Favorable 50 20-71 23 41 16-81 153 .16 
 Intermediate 62 21-81 50 60 16-84 333 .50 
 Unfavorable 64 23-83 35 62 15-88 235 .019 
With trisomy 8Without trisomy 8P
MedianRangeNMedianRangeN
Peripheral blasts (%)        
 Favorable 11 0-79 22 31% 0%-97% 140 .048 
 Intermediate 10 0-95 47 35% 0%-99% 313 .0088 
 Unfavorable 11 0-99 34 24% 0%-99% 225 .27 
WBC (1000/mm3)        
 Favorable 4.7 0.8-60.6  23 7.3 0.5-206.4 150 .55 
 Intermediate 7.4 1.1-104.6 50 19.7 0.3-274.0 330 .0061 
 Unfavorable 6.2 0.8-271.2 34 8.3 0.6-230.0 234 .64 
Age (y)        
 Favorable 50 20-71 23 41 16-81 153 .16 
 Intermediate 62 21-81 50 60 16-84 333 .50 
 Unfavorable 64 23-83 35 62 15-88 235 .019 

Comparisons that reached statistical significance in any of the risk group categories are included regardless of whether the risk group/+ 8 interaction was statistically significant.

[ViewLarge]
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal